These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25040895)

  • 61. Decreasing prevalence and stagnating incidence of Hepatitis C-co-infection among a cohort of HIV-1-positive patients, with a majority of men who have sex with men, in Germany, 1996-2019.
    Krings A; Schmidt D; Meixenberger K; Bannert N; Münstermann D; Tiemann C; Kollan C; Gunsenheimer-Bartmeyer B
    J Viral Hepat; 2022 Jun; 29(6):465-473. PubMed ID: 35302675
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.
    Rao VB; Johari N; du Cros P; Messina J; Ford N; Cooke GS
    Lancet Infect Dis; 2015 Jul; 15(7):819-24. PubMed ID: 25957078
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.
    Zhou YB; Liang S; Wang QX; Gong YH; Nie SJ; Nan L; Yang AH; Liao Q; Song XX; Jiang QW
    BMC Infect Dis; 2014 Mar; 14():134. PubMed ID: 24612875
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country.
    Nutini MFR; Hunter J; Giron L; Pires AFNPC; Kohiyama IM; Camargo M; Sucupira MCA; Benzaken AS; Ferreira PA; Truong HM; Diaz RS
    PLoS One; 2020; 15(1):e0227082. PubMed ID: 31905224
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients.
    Lewden C; Jacqmin-Gadda H; Vildé JL; Bricaire F; Waldner-Combernoux A; May T; Cuzin L; Lang JM; Leport C; Chêne G;
    HIV Clin Trials; 2004; 5(4):224-31. PubMed ID: 15472797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epidemiology of hepatitis C virus in HIV-infected patients.
    Peters L; Klein MB
    Curr Opin HIV AIDS; 2015 Sep; 10(5):297-302. PubMed ID: 26248117
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alcohol misuse and illicit drug use are associated with HCV/HIV co-infection.
    Simon D; Michita RT; Béria JU; Tietzmann DC; Stein AT; Lunge VR
    Epidemiol Infect; 2014 Dec; 142(12):2616-23. PubMed ID: 24512701
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Perceived risk for severe outcomes and drinking status among drug users with HIV and Hepatitis C Virus (HCV).
    Elliott JC; Hasin DS; Des Jarlais DC
    Addict Behav; 2016 Dec; 63():57-62. PubMed ID: 27423099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection.
    Kim AY; Onofrey S; Church DR
    J Infect Dis; 2013 Mar; 207 Suppl 1(Suppl 1):S1-6. PubMed ID: 23390299
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Limited impact of the harm-reduction policy on HCV among drug-users. The ANRS-Coquelicot survey example].
    Jauffret-Roustide M; Emmanuelli J; Desenclos JC
    Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S53-1S59. PubMed ID: 17073130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
    Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP;
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):786-791. PubMed ID: 28418984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug Abuse, HIV, and HCV in Asian Countries.
    Hser YI; Liang D; Lan YC; Vicknasingam BK; Chakrabarti A
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):383-93. PubMed ID: 27000123
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.
    Jauffret-Roustide M; Le Strat Y; Couturier E; Thierry D; Rondy M; Quaglia M; Razafandratsima N; Emmanuelli J; Guibert G; Barin F; Desenclos JC
    BMC Infect Dis; 2009 Jul; 9():113. PubMed ID: 19607712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neuropsychiatric impact of hepatitis C on advanced HIV.
    Ryan EL; Morgello S; Isaacs K; Naseer M; Gerits P;
    Neurology; 2004 Mar; 62(6):957-62. PubMed ID: 15037699
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infection.
    Meijide H; Mena Á; Rodríguez-Osorio I; Pértega S; Castro-Iglesias Á; Rodríguez-Martínez G; Pedreira J; Poveda E
    Enferm Infecc Microbiol Clin; 2017 Jan; 35(1):20-26. PubMed ID: 27609631
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Hepatitis C virus infection in internal medicine and infectious diseases departments in France. Preliminary results of a national epidemiological survey].
    Cacoub P; Raguin G; Veyssier P; Piette JC; Micoud M; Godeau P
    Presse Med; 1996 Mar 2-9; 25(8):349-52. PubMed ID: 8685181
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015.
    van Santen DK; van der Helm JJ; Lindenburg K; Schim van der Loeff M; Prins M
    Int J Drug Policy; 2017 Sep; 47():95-101. PubMed ID: 28606392
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia.
    Moorman JP; Krolikowski MR; Mathis SM; Pack RP
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):308-314. PubMed ID: 29931466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmission.
    Chanbancherd P; Paris RM; Torugsa K; Myint KS; Sangkharomya S; Brown AE
    AIDS; 2004 Nov; 18(17):2339-41. PubMed ID: 15577552
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort.
    Lebrun D; Hentzien M; Cuzin L; Rey D; Joly V; Cotte L; Allavena C; Dellamonica P; Servettaz A; Bani-Sadr F;
    AIDS; 2017 Sep; 31(15):2159-2166. PubMed ID: 28723711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.